Skip to main content

UBS Group AG

Position in CNSP — CNS Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in CNSP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,983
+$5,241 QoQ
Shares Held
1,461
+100.4% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 11 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. CNSP ranks #461 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CNSP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,983 1,461
2026-03-31 $1,742 729
2025-12-31 $3,207 611
2025-09-30 $94,680 10,520
2025-06-30 $26,484 32,103
2025-03-31 $32,609 23,978
2024-12-31 $7,729 64,418
2024-09-30 $23,824 181,866
2024-06-30 $4,153 2,629
2023-09-30 $62 55
2023-06-30 $2,510 1,126
2023-03-31 $2,456 2,457
2022-12-31 $2,911 1,213
2021-12-31 3,653
2021-06-30 4,676
2021-03-31 1,360
2020-09-30 3,960
2020-03-31 1,930